GV20-0251
N/A
Report date: 2026/05/20 20:02:01
Base Information
Drug NameGV20-0251
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[22]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesChance Pharmaceuticals
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesCancer Hospital Of Chinese Academy Of Medical SciencesChance PharmaceuticalsShanghai Xunbaihui Biotechnology Co Ltd
Inactive CompaniesN/A
Active Indications +[21]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A